FORBES-TATE

Lobbying for IONIS PHARMACEUTICAL, INC. · Biopharmaceutical company developing RNA therapies.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income · posted Jan 18, 2026

Bills named in this filing 1

Lobbying activity 2

Health Issues

Issues related to the reintroduction of the Creating Hope Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.

Medicare/Medicaid

Issues related to the reintroduction of the Creating Hope Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.